Moderna said Monday that the biotechnology company will file for emergency approval of its coronavirus vaccine. The company says its vaccine has shown 94% effectiveness in late-stage clinical trials. 

The company is just one of three that has a vaccine on the verge of federal approval that could lead to vaccinations in the U.S. in the coming weeks or months.

You Might Like
Learn more about RevenueStripe...